C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 5/023 (2006.01) A61K 38/06 (2006.01) C07K 5/02 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2325629
The invention concerns novel crystalline forms of 1S-[1alpha(2S*, 3R*),9alpha]-6, 10-dioxo-N- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl)-9-[[( 1-isoquinolyl) carbonyl]-amino] octahydro-6H -piridazino[1, 2-a][1,2]diazepin-1 -carboxamide, anhydrous (form A) and hydrated (form B), the method for preparing them, their use as medicine and the pharmaceutical compositions containing them.
L'invention a pour objet les nouvelles formes cristallines du 1S-[1alpha(2S*, 3R*),9alpha]6, 10-dioxo-N- (2-éthoxy-5 -oxo-tétrahydro-3 -furanyl)-9 [[( 1- isoquinolyl) carbonyl]amino] octahydro-6H -piridazino[1, 2-a][1 ,2]diazepine-1 -carboxamide anhydre (forme A) et hydratée (forme B), leur procédé de préparation, leur application à titre de médicament et les compositions pharmaceutiques les renfermant.
Godard Jean-Yves
Rognon Valerie
Aventis Pharma S.a.
Hoechst Marion Roussel
Robic
LandOfFree
Crystalline forms of 1s-[1alpha (2s*,3r*), 9alpha]-6,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline forms of 1s-[1alpha (2s*,3r*), 9alpha]-6,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline forms of 1s-[1alpha (2s*,3r*), 9alpha]-6,... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2011055